Investing.com – U.S. stocks were mixed after the close on Friday, as gains in the Financials, Utilities and Consumer Goods sectors... Investing.com -- U.S. stocks rallied from a considerable ...

Investing.com – U.S. stocks closed higher on Friday, as investors shrugged off U.S. political turmoil and piled back into... Investing.com – U.S. stocks were higher after the close on Friday ...

Merck's revenues are driven by cancer med Keytruda, which faces patent expiry by 2028. See why I rate MRK stock a hold.

Read more on 2 durable dividend stocks that offer higher yields and strong cash flows, outperforming the S&P 500 in value, ...

Results from Phase 2a Trial demonstrate a good safety and tolerability profile of VXM01 and Avelumab Combination Therapy in Glioblastoma, supporting further investigation ...